U
LumiraDx Limited LMDXF
OTC PK
Recommendation
--
Prev Close
$0.01
Volume
--
Avg Vol (90D)
217,749
Market Cap
$3.59M
Dividend & Yield
--
52-Week Range
$0.00 - $0.3059
P/E (TTM)
--
EPS (TTM)
-$0.4762
My Lists My Alerts
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$341.61M
Total Debt (Q)
$460.52M
Total Liabilities (Q)
$555.55M
Book Value Per Share (Q)
-$0.6706
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, October 3, 2023
Period Date
Friday, June 30, 2023
Next Filing
(est)
Price History
Loading...
Beta
616.67
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Jul 31, 2024 - $0.00
52-week High
Nov 30, 2023 - $0.3059
Valuation
Market Cap
$3.59M - Nano Cap
Enterprise Value
$438.65M
Price/Sales (TTM)
0.05
Price/Book (Q)
-0.01
Dividends and Shares
Shares Outstanding
318.88M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lumiradx.com
Phone Number
44 11 7284 2535
Address
3 More London Riverside
London, SE1 2AQ
Country
United Kingdom
Year Founded
--
Business Description
Sector
--
Industry
--
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare... more
Weiss Ratings